X4 Pharmaceuticals to Participate in Guggenheim, Stifel, and Jefferies Conferences in November 2026
Globe Newswire•03/11/2026•16:30 ET
0
Key Highlights
- ➤X4 Pharmaceuticals (XFOR) to participate in three healthcare investment conferences in November 2026
- ➤Management scheduled Guggenheim fireside chat for November 10 at 1:00 pm ET
- ➤Management scheduled Stifel fireside chat for November 12 at 9:20 am ET
- ➤Jefferies conference corporate presentation set for November 16 at 12:00 pm GMT
- ➤XOLREMDI approved in U.S. and EU for patients with WHIM syndrome
BOSTON, Nov. 03, 2026 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (Nasdaq: XFOR), a company focused on improving the lives of people with rare hematology diseases, today announced that management will participate in several upcoming investment conferences in November 2026:
Guggenheim 3rd Annual Healthcare Innovation Conference Tuesday, November 10, 2026 at 1:00 pm ET - Fireside Chat
Get started
Create a free account to read the full story.